TNFRSF13C and follicular lymphoma: Both BAFF‐R monoclonal antibody and BAFF‐R CAR T cells treatments have shown cytotoxic efficacy against various B‐cell malignancies, including acute lymphocytic lymphoma, follicular lymphoma, mantle cell lymphoma, and diffuse large B‐cell lymphoma.35, 47